American Capital Advisory’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21K Sell
10
-3
-23% -$830 ﹤0.01% 601
2026
Q1
$3.84K Buy
13
+5
+63% +$1.49K ﹤0.01% 431
2025
Q4
$2.19K Buy
8
+2
+33% +$543 ﹤0.01% 451
2025
Q3
$1.62K Sell
6
-2
-25% -$544 ﹤0.01% 460
2025
Q2
$2.21K Buy
8
+5
+167% +$1.36K ﹤0.01% 401
2025
Q1
$796 Buy
+3
New +$740 ﹤0.01% 457

Other funds holding CME

American Capital Advisory's CME Position: Q2 2026 in Review

American Capital Advisory reduced its CME Group (CME) stake by 23% in Q2 2026, selling an estimated $830 and leaving 10 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #601.

American Capital Advisory first reported a position in CME in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.84K in Q1 2026. 956 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • American Capital Advisory held 10 shares of CME Group worth $2.21K as of Q2 2026.
  • American Capital Advisory sold 3 CME Group shares in Q2 2026, an estimated $830.
  • CME Group made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #601 holding.
  • American Capital Advisory first reported a position in CME Group in Q1 2025 and has held it in 6 quarters since.
  • American Capital Advisory's CME Group position peaked at $3.84K in Q1 2026.
  • 956 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.